Tenon Medical, Inc. (TNON) Price & Analysis

Q: What was Tenon Medical, Inc.’s price range in the past 12 months?

Tenon Medical, Inc. lowest stock price was $0.85 and its highest was $5.85 in the past 12 months.

Q: What is Tenon Medical, Inc.’s market cap?

Tenon Medical, Inc.’s market cap is $11.77M.

Q: When is Tenon Medical, Inc.’s upcoming earnings report date?

Tenon Medical, Inc.’s upcoming earnings report date is Mar 05, 2026 which is in 75 days.

Q: How were Tenon Medical, Inc.’s earnings last quarter?

Tenon Medical, Inc. released its earnings results on Nov 13, 2025. The company reported -$0.4 earnings per share for the quarter, missing the consensus estimate of -$0.37 by -$0.03.

Q: Is Tenon Medical, Inc. overvalued?

According to Wall Street analysts Tenon Medical, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Q: Does Tenon Medical, Inc. pay dividends?

Tenon Medical, Inc. does not currently pay dividends.

Q: What is Tenon Medical, Inc.’s EPS estimate?

Tenon Medical, Inc.’s EPS estimate is -0.36.

Q: How many shares outstanding does Tenon Medical, Inc. have?

Tenon Medical, Inc. has 11,106,444 shares outstanding.

Q: What happened to Tenon Medical, Inc.’s price movement after its last earnings report?

Tenon Medical, Inc. reported an EPS of -$0.4 in its last earnings report, missing expectations of -$0.37. Following the earnings report the stock price went same 0%.

Q: Which hedge fund is a major shareholder of Tenon Medical, Inc.?

Currently, no hedge funds are holding shares in TNON

Compare

278 Followers

TNON Stock Chart & Stats

$1.07

-$0.13(-5.94%)

At close: Jan 08 4:00 PM EST

$1.07

-$0.13(-5.94%)

Day’s Range― - ―

52-Week Range$0.85 - $5.85

Previous CloseN/A

Volume74.29K

Average Volume (3M)189.55K

Market Cap

$11.77M

Enterprise Value$3.62M

Total Cash (Recent Filing)$3.44M

Total Debt (Recent Filing)$216.00K

Price to Earnings (P/E)―

Beta1.45

Next Earnings

Mar 05, 2026

EPS Estimate

-0.36

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.40

Shares Outstanding11,106,444

10 Day Avg. Volume240,436

30 Day Avg. Volume189,548

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)0.38

Price to Sales (P/S)0.70

P/FCF Ratio-0.23

Enterprise Value/Market Cap0.31

Enterprise Value/Revenue1.12

Enterprise Value/Gross Profit2.13

Enterprise Value/Ebitda-0.29

Forecast

1Y Price Target

$2.75

Price Target Upside157.01% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Acquisition StrategyThe acquisition of sacroiliac (SI) joint-specific assets from SiVantage broadens Tenon Medical's SI joint fusion portfolio and strengthens its competitive positioning.

Product Launch And InnovationThe company is expected to initiate a pilot launch of SImmetry+ in 4Q25, with a broader commercial rollout planned for 2026, highlighting ongoing commitment to innovation.

Revenue GrowthThe company reported record revenue in 3Q25, supported by the highest Catamaran procedure volume to date and the initial contribution from SImmetry+.

Bears Say

Operating ExpensesThe GAAP loss per share was slightly wider than consensus due to higher-than-expected operating expenses, elevated by integration costs from the acquisition of SiVantage SImmetry.

Revenue EstimatesRevenue for 2Q25 was below consensus, and 2025 and 2026 revenue estimates have been lowered due to recalibration.

Tenon Medical, Inc. News

Tenon Medical files to sell 5.43M shares of common stock for holders

06:05 EST Tenon Medical (TNON) files to sell 5.43M shares of common stock for holders Published first on...

10d ago

TNON

Tenon Medical announces completion of initial cases with SImmetry+ system

Tenon Medical (TNON) announced the completion of the first clinical procedures utilizing the Company’s new SImmetry+ SI Joint...

16d ago

TNON

Tenon Medical Secures $2.85 Million in Stock Offering

An announcement from Tenon Medical, Inc. ( ($TNON) ) is now available. On November 10, 2025, Tenon Medical,...

1M ago

TNON

Tenon Medical, Inc. Receives Buy Rating from Anthony Vendetti Amid Record Revenue and Strategic Expansion

Tenon Medical, Inc., the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Anthony Vendetti...

1M ago

TNON

Tenon Medical’s Earnings Call: Record Growth Amid Challenges

Tenon Medical, Inc. (($TNON)) has held its Q3 earnings call. Read on for the main highlights of the...

1M ago

TNON

Tenon Medical price target lowered to $2.50 from $2.75 at Alliance Global

Alliance Global lowered the firm’s price target on Tenon Medical (TNON) to $2.50 from $2.75 and keeps a...

1M ago

TNON

Tenon Medical Reports Q3 2025 Financial Results

Tenon Medical, Inc. ( ($TNON) ) has released its Q3 earnings. Here is a breakdown of the information...

1M ago

TNON

Tenon Medical prices 2.2M shares at $1.285 in PIPE financing

Tenon Medical (TNON) announced the pricing of an at-the-market private investment in public equity financing with several accredited...

1M ago

TNON

Tenon Medical, Inc. (TNON) Q3 Earnings Cheat Sheet

Tenon Medical, Inc. (TNON) is scheduled to report 3rd quarter earnings on 11/13/2025, after the market closes. Regarding...

1M ago

TNON

Strategic Acquisitions and Product Innovations Drive Buy Rating for Tenon Medical, Inc.

In a report released yesterday, Anthony Vendetti from Maxim Group reiterated a Buy rating on Tenon Medical, Inc.,...

2M ago

TNON

Tenon Medical announces 510(k) clearance for SImmerty+ SI Joint Fusion System

Tenon Medical (TNON) has received U.S. Food and Drug Administration 510(k) clearance for the SImmetry+ SI Joint Fusion...

2M ago

TNON

Tenon Medical Issues Restricted Stock Units to Directors

An announcement from Tenon Medical, Inc. ( ($TNON) ) is now available. On October 13, 2025, Tenon Medical,...

2M ago

TNON

Tenon Medical Approves Key Proposals at Annual Meeting

An announcement from Tenon Medical, Inc. ( ($TNON) ) is now available. Tenon Medical, Inc. held its 2025...

3M ago

TNON

Tenon Medical announces Catamaran Mainsail study publication

Tenon Medical (TNON) announced the second interim analysis publication from its ongoing MAINSAIL study, a prospective, single-arm, multi-center,...

4M ago

TNON

TNON FAQ

What was Tenon Medical, Inc.’s price range in the past 12 months?

Tenon Medical, Inc. lowest stock price was $0.85 and its highest was $5.85 in the past 12 months.

What is Tenon Medical, Inc.’s market cap?

Tenon Medical, Inc.’s market cap is $11.77M.

When is Tenon Medical, Inc.’s upcoming earnings report date?

Tenon Medical, Inc.’s upcoming earnings report date is Mar 05, 2026 which is in 75 days.

How were Tenon Medical, Inc.’s earnings last quarter?

Tenon Medical, Inc. released its earnings results on Nov 13, 2025. The company reported -$0.4 earnings per share for the quarter, missing the consensus estimate of -$0.37 by -$0.03.

Is Tenon Medical, Inc. overvalued?

According to Wall Street analysts Tenon Medical, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Tenon Medical, Inc. pay dividends?

Tenon Medical, Inc. does not currently pay dividends.

What is Tenon Medical, Inc.’s EPS estimate?

Tenon Medical, Inc.’s EPS estimate is -0.36.

How many shares outstanding does Tenon Medical, Inc. have?

Tenon Medical, Inc. has 11,106,444 shares outstanding.

What happened to Tenon Medical, Inc.’s price movement after its last earnings report?

Tenon Medical, Inc. reported an EPS of -$0.4 in its last earnings report, missing expectations of -$0.37. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Tenon Medical, Inc.?

Currently, no hedge funds are holding shares in TNON

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Tenon Medical, Inc.

Tenon Medical, Inc. (TNON) is a medical device company focused on developing innovative solutions for the treatment of spinal conditions. The company operates primarily in the healthcare sector, specializing in minimally invasive surgical products designed to enhance patient outcomes and streamline surgical procedures. Tenon Medical's core offerings include advanced spinal implants and instrumentation aimed at addressing complex spinal disorders, catering to both surgeons and patients through their state-of-the-art technology and design.

Tenon Medical, Inc. (TNON) Earnings & Revenues

Historic Earnings Reports

TNON Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call reflects strong operational and strategic progress with record revenue growth, successful integration of acquisitions, and key product launches. However, challenges persist with increased operating expenses and a notable net loss, although mitigated by improved gross profit margins and no outstanding debt.View all TNON earnings summaries

TNON Stock 12 Month Forecast

Average Price Target

$2.75

▲(157.01% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","1":"$1","2":"$2","3":"$3","4":"$4"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$3.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$2.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1,2,3,4],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.11,1.2553846153846155,1.4007692307692308,1.5461538461538462,1.6915384615384617,1.836923076923077,1.9823076923076925,2.1276923076923078,2.273076923076923,2.4184615384615387,2.5638461538461543,2.7092307692307696,2.8546153846153848,{"y":3,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.11,1.2361538461538462,1.3623076923076924,1.4884615384615385,1.6146153846153846,1.7407692307692308,1.866923076923077,1.9930769230769232,2.1192307692307693,2.2453846153846153,2.371538461538462,2.497692307692308,2.623846153846154,{"y":2.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.11,1.216923076923077,1.323846153846154,1.4307692307692308,1.5376923076923077,1.6446153846153848,1.7515384615384617,1.8584615384615386,1.9653846153846155,2.0723076923076924,2.1792307692307693,2.286153846153846,2.393076923076923,{"y":2.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.75,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.28,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.88,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.34,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.69,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.18,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.08,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.04,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.46,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.22,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.22,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.11,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >